GLG News by Corneal Transplantation Surgeons (US)

The authors show less than stellar results following attempted enhancements of undercorrected or regressed myopic lasik. There are several alternatives to enhancement, including a repeat Lasik at a more shallow depth, lifting the previous Lasik flap and repeating the treatment, or a surface procedure.Surface...

Refractive surgery is taken for granted by patients to "get rid of their glasses and contact lenses". They rarely consider the possibility of loss of vision.

    The VEGF Trap from Regeneron is a protein made up off human VEGF receptors fused to human immunoglobulin.  This compound binds VEGF, preventing VEGF from binding to its natural receptors, interrupting the angiogenic cascade.    The phase II study showed promising...

This article describes the perspective of a retinal specialist on the Avastin/Lucentis controversy.  In mid-February the National Institutes of Health announced that it would conduct a head to head trial comparing the effectiveness of Lucentis and Avastin for the treatment of wet  age...

This New York Times article describes many of the vision correction options available to individuals with presbyopia.  Because of the growing population of baby boomers, there is significant public interest in options that allow individuals freedom from reading glasses.  Multifocal contact...

This article presents the results of a study comparing standard phacoemulsification to Aqualase.  Complication rates were similar between the two procedures.  The 63 patient study looked in particular at foveal thickening after surgery.  While no statistical significance was demonstrated,...

The early results of a new corneal inlay (PresbyLens, ReVision Optics) are presented.  A corneal inlay is placed underneath a LASIK corneal flap in the non-dominant eye to correct presbyopia.  This version of a corneal inlay is 1.5mm in diameter.  The outcomes of 15 patients showed good...

The recent approval of the aspheric version of the Restor multifocal intraocular lens is positive as most surgeons already understand the value of aspheric optics.  As shown with monofocal aspheric lenses, such as the Alcon IQ, Advanced Medical Optics' Tecnis, and Bausch and Lomb's Sofport, aspheric...

The article describes some of the legal concerns in billing for presbyopia-correcting IOLs.  The ruling by the CMS (Centers for Medicaid and Medicare Services) in 2005 that essentially allowed surgeons to charge patients an additional out-of-pocket cost related to the implantation of these lenses...

The Phase III Trials of Xibrom showed excellent efficacy in the treatment of post cataract surgery pain and inflammation.  The trial involved 500 cataract patients and is important in that it demonstrates that a once-a-day formulation is effacacious in treating patients post-operatively. ...